Revolution Medicines, Inc. <RVMD.O>: Truist Securities raises target price to $231 from $210
RVMD•Related News
Joby Aviation to acquire defense tech firm Resonant Sciences for about $500 million
JOBY•
Imunon Q2 FY26 net loss widens to $2.8 million
IMNN•
Aaon, Inc. <AAON.O>: Oppenheimer cuts target price to $125 from $145
AAON•
LivePerson urges shareholders to back SoundHound merger ahead of Aug. 20 vote
LPSN•
Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy
STIM•